<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The association of Epstein-Barr virus (EBV) with 85 non-Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of the digestive tract in nonimmunocompromised cases was investigated, using in situ hybridization technique to detect EBV encoded small <z:chebi fb="40" ids="33697">RNAs</z:chebi> in paraffin sections </plain></SENT>
<SENT sid="1" pm="."><plain>85 cases (83 B-cell type and 2 T-cell type) included 3 gingivas, 1 tongue, 3 palates, 10 tonsils, 43 stomachs, 2 jejunums, 12 ileums, 3 ileo-cecal regions, 5 colons and 3 rectums </plain></SENT>
<SENT sid="2" pm="."><plain>Out of 85 cases, 4 (4.7%) were EBV-positive, comprising 1 B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of the tonsil, 2 B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of the stomach, and 1 T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of the rectum </plain></SENT>
<SENT sid="3" pm="."><plain>On the other hand, EBV-positive rate in nasal/nasopharyngeal <z:hpo ids='HP_0002665'>lymphomas</z:hpo> examined for comparison was very high, 81.8% (9 out of 11) </plain></SENT>
<SENT sid="4" pm="."><plain>These results show that EBV is associated with only a small proportion of <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of the digestive tract in nonimmunocompromised case, suggesting the existence of the other oncogenetic factors in the pathogenesis of this group of <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>